In our study, the promoter methylation levels of cGAS and MAVS were elevated, which may affect the function of innate immunity of the cGAS/STING and RIG-I/MAVS pathways in the development of CPL. Here, CGAS is linked to congenital pulmonary lymphangiectasia.